Home » EPIC Archives: AVCT (page 3)

AVCT News Archives

Antibody Mimetics

Avacta Group Plc

“The sad fact is that around 70% of cancer patients with solid based tumors don’t respond to classical chemotherapy,” said Joseph Tabernero, MD, PhD, head of Val d’Hebron Institute of ...

Read Article »

Avacta will be at WRIB

Avacta Group Plc

Attending WRIB next week? The Avacta team are, and will be found on booth 61. A Week of Bioanalysis, Biomarkers, and Immunogenecity at WRIB Avacta Group Plc (LON:AVCT) principal focus ...

Read Article »